Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class i and II alleles

Gastroenterology

Volumn 141, Issue 1, 2011, Pages 338-347

  Lucena, M Isabel ^a   Molokhia, Mariam ^b   Shen, Yufeng ^c   Urban, Thomas J ^d   Aithal, Guruprasad P ^e   Andrade, Ral J ^a   Day, Christopher P ^f   Ruizcabello, Francisco ^g,h   Donaldson, Peter T ^f   Stephens, Camilla ^a   Pirmohamed, Munir ⁱ   Romerogomez, Manuel ^j   Navarro, Jose Maria ^k   Fontana, Robert J ^l   Miller, Michael ^m   Groome, Max ^m   Bondonguitton, Emmanuelle ⁿ   Conforti, Anita ^o   Stricker, Bruno H C ^p   Carvajal, Alfonso ^q   Ibanez, Luisa ^r   Yue, Qunying ^s   Eichelbaum, Michel ^t   Floratos, Aris ^c   Pe'Er, Itsik ^c   Daly, Mark J ^u   Goldstein, David B ^d   Dillon, John F ^m   Nelson, Matthew R ^v   Watkins, Paul B ^w   Daly, Ann K ^f   more..

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d DUKE UNIVERSITY   (United States)

^e NIHR NOTTINGHAM BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

^g HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^h Red Genómica Del Cáncer   (Spain)

ⁱ UNIVERSITY OF LIVERPOOL   (United Kingdom)

^j HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^k HOSPITAL COSTA DEL SOL   (Spain)

^l UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^m UNIVERSITY OF DUNDEE   (United Kingdom)

ⁿ UNIVERSITÉ DE TOULOUSE   (France)

^o UNIVERSITY HOSPITAL OF VERONA   (Italy)

^p ERASMUS MEDICAL CENTER   (Netherlands)

^q UNIVERSITY OF VALLADOLID   (Spain)

^r Fundacion Institut Catala de Farmacologia   (Spain)

^s MEDICAL PRODUCTS AGENCY   (Sweden)

^t UNIVERSITY OF TÜBINGEN   (Germany)

^u HARVARD MEDICAL SCHOOL   (United States)

^v GLAXOSMITHKLINE   (United States)

^w Hamner UNC   (United States)

more..

Author keywords

Genome Wide Association Study; GWAS; Hepatotoxicity; Pharmacogenomics

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ADAPTIVE IMMUNITY; ADULT; ALLELE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HLA MATCHING; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TOXIC HEPATITIS;

EID: 79957523368     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.04.001     Document Type: Article

References (38)

1. N. Kaplowitz Idiosyncratic drug hepatotoxicity Nat Rev Drug Discov 4 2005 489 499 (Pubitemid 40861991)
2. C. Sgro, F. Clinard, and K. Ouazir Incidence of drug-induced hepatic injuries: a French population-based study Hepatology 36 2002 451 455 (Pubitemid 34810366)
3. G. Ostapowicz, R.J. Fontana, and F.V. Schiodt Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States Ann Intern Med 137 2002 947 954 (Pubitemid 35440240)
4. B.H. Stricker, J.W. Van den Broek, and J. Keuning Cholestatic hepatitis due to antibacterial combination of amoxicillin and clavulanic acid (augmentin) Dig Dis Sci 34 1989 1576 1580 (Pubitemid 19255351)
5. F.J. de Abajo, D. Montero, and M. Madurga Acute and clinically relevant drug-induced liver injury: a population based case-control study Br J Clin Pharmacol 58 2004 71 80 (Pubitemid 38901470)
6. R.J. Andrade, M.I. Lucena, and M.C. Fernandez Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period Gastroenterology 129 2005 512 521 (Pubitemid 41096639)
7. N. Chalasani, R.J. Fontana, and H.L. Bonkovsky Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States Gastroenterology 135 2008 1924 1934 e1e4
8. R.J. Andrade, M.I. Lucena, and N. Kaplowitz Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry Hepatology 44 2006 1581 1588 (Pubitemid 44953663)
9. L.A. Garcia Rodriguez, B.H. Stricker, and H.J. Zimmerman Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid Arch Intern Med 156 1996 1327 1332 (Pubitemid 26196892)
10. R.J. Fontana, A.O. Shakil, and J.K. Greenson Acute liver failure due to amoxicillin and amoxicillin/clavulanate Dig Dis Sci 50 2005 1785 1790 (Pubitemid 41413891)
11. M.L. Hautekeete, Y. Horsmans, and C. van Waeyenberge HLA association of amoxicillin-clavulanate-induced hepatitis Gastroenterology 117 1999 1181 1186 (Pubitemid 29512678)
12. J. O'Donohue, K.A. Oien, and P. Donaldson Co-amoxiclav jaundice: clinical and histological features and HLA class II association Gut 47 2000 717 720
13. P.T. Donaldson, A.K. Daly, and J. Henderson Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury J Hepatol 53 2010 1049 1053
14. R.J. Andrade, M.I. Lucena, and A. Alonso HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease Hepatology 39 2004 1603 1612 (Pubitemid 38702661)
15. M.I. Lucena, R.J. Andrade, and M.C. Fernandez Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain Hepatology 44 2006 850 856 (Pubitemid 46489548)
16. A.K. Daly, P.T. Donaldson, and P. Bhatnagar HLA-B (*)5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin Nat Genet 41 2009 816 819
17. M. Molokhia, and P. McKeigue EUDRAGENE: European collaboration to establish a case-control DNA collection for studying the genetic basis of adverse drug reactions Pharmacogenomics 7 2006 633 638
18. R.J. Fontana, P.B. Watkins, and H.L. Bonkovsky Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct Drug Saf 32 2009 55 68
19. G. Danan, and C. Benichou Causality assessment of adverse reactions to drugs I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries J Clin Epidemiol 46 1993 1323 1330 (Pubitemid 23333873)
20. M.R. Nelson, K. Bryc, and K.S. King The Population Reference Sample, POPRES: a resource for population, disease, and pharmacological genetics research Am J Hum Genet 83 2008 347 358
21. S. Purcell, B. Neale, and K. Todd-Brown PLINK: a tool set for whole-genome association and population-based linkage analyses Am J Hum Genet 81 2007 559 575 (Pubitemid 47330214)
22. S.R. Browning, and B.L. Browning Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering Am J Hum Genet 81 2007 1084 1097 (Pubitemid 47580259)
23. The R Project for Statistical Computing http://www.r-project.org Accessed March 9, 2011
24. J. Novembre, T. Johnson, and K. Bryc Genes mirror geography within Europe Nature 456 2008 98 101
25. P.I. de Bakker, G. McVean, and P.C. Sabeti A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC Nat Genet 38 2006 1166 1172 (Pubitemid 44470362)
26. K.R. Ahmadi, M.E. Weale, and Z.Y. Xue A single-nucleotide polymorphism tagging set for human drug metabolism and transport Nat Genet 37 2005 84 89 (Pubitemid 40070944)
27. L.A. Hindorff, H.A. Junkins, and J.P. Mehta A catalog of published genome-wide association studies www.genome.gov/gwastudies/ Accessed March 9, 2011
28. S.A. Chung, and L.A. Criswell PTPN22: its role in SLE and autoimmunity Autoimmunity 40 2007 582 590
29. N. Kaniwa, Y. Saito, and M. Aihara HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis Pharmacogenomics 9 2008 1617 1622
30. J.H. Moore, and S.M. Williams Epistasis and its implications for personal genetics Am J Hum Genet 85 2009 309 320
31. G.M. Hirschfield, X. Liu, and C. Xu Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants N Engl J Med 360 2009 2544 2555
32. C. Selmi, and M.E. Gershwin The role of environmental factors in primary biliary cirrhosis Trends Immunol 30 2009 415 420
33. J.B. Singer, S. Lewitzky, and E. Leroy A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury Nat Genet 42 2010 711 714
34. A. Kindmark, A. Jawaid, and C.G. Harbron Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis Pharmacogenomics J 8 2008 186 195 (Pubitemid 351712643)
35. C.F. Spraggs, L.R. Budde, and L.P. Briley HLA-DQA1 (*)02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer J Clin Oncol 29 2011 667 673
36. K. Hirata, H. Takagi, and M. Yamamoto Ticlopidine-induced hepatotoxicity is associated with specific human leukocyte antigen genomic subtypes in Japanese patients: a preliminary case-control study Pharmacogenomics J 8 2008 29 33
37. S.P. Dickson, K. Wang, and I. Krantz Rare variants create synthetic genome-wide associations PLoS Biol 8 2010 e1000294
38. E.A. Ashley, A.J. Butte, and M.T. Wheeler Clinical assessment incorporating a personal genome Lancet 375 2010 1525 1535